{"id":"terbutaline-sulphate","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Tremors"},{"rate":"5-10%","effect":"Nervousness"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Palpitations"},{"rate":"5-10%","effect":"Dizziness"}]},"_chembl":{"chemblId":"CHEMBL1315867","moleculeType":"Small molecule","molecularWeight":"548.66"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This leads to relaxation of bronchial smooth muscle, resulting in increased airflow to the lungs and relief of bronchospasm symptoms. Terbutaline sulphate is a selective beta-2 agonist, which means it has a higher affinity for beta-2 receptors than beta-1 receptors, reducing the risk of cardiac side effects.","oneSentence":"Terbutaline sulphate is a beta-2 adrenergic receptor agonist that works by stimulating the beta-2 receptors in the lungs to cause bronchodilation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:38:08.944Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma"},{"name":"Chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT04973345","phase":"PHASE2, PHASE3","title":"Terbutaline Sulfate in Adults With Asthma","status":"WITHDRAWN","sponsor":"Kanecia Obie Zimmerman","startDate":"2023-07-07","conditions":"Asthma","enrollment":""},{"nctId":"NCT05193968","phase":"NA","title":"Hot Flashes and Neurovascular Function in Women","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2022-02-24","conditions":"Hot Flashes, Menopause, Vasomotor System; Labile","enrollment":120},{"nctId":"NCT04278404","phase":"","title":"Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)","status":"RECRUITING","sponsor":"Duke University","startDate":"2020-03-05","conditions":"Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension, Urinary Tract Infections in Children","enrollment":5000},{"nctId":"NCT06626620","phase":"PHASE3","title":"Randomized Controlled Trial of Intravenous Magnesium Sulfate Versus Terbutaline for Children in the Management of Acute Exacerbation of Asthma","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2024-01-01","conditions":"Acute Exacerbation of Asthma","enrollment":120},{"nctId":"NCT06535087","phase":"","title":"The Impact of Airway Allergic Diseases on Children's and Parents' Quality of Life","status":"RECRUITING","sponsor":"Wenjing Zhou","startDate":"2024-07-20","conditions":"Pediatric Asthma, Rhinitis, Allergic, Quality of Life","enrollment":600},{"nctId":"NCT04527016","phase":"PHASE4","title":"Airway Microbiota Based Treatment of Asthma in Preschool Children","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2021-10-18","conditions":"Asthma in Children","enrollment":120},{"nctId":"NCT04433104","phase":"PHASE1, PHASE2","title":"Umbilical Cord Mesenchymal Stem Cells Transplantation in the Treatment of Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Vinmec Research Institute of Stem Cell and Gene Technology","startDate":"2020-06-09","conditions":"COPD","enrollment":40},{"nctId":"NCT00802230","phase":"PHASE4","title":"Pharmacodynamic Study of Carvedilol Versus Metoprolol in Heart Failure","status":"COMPLETED","sponsor":"University of Utah","startDate":"2002-09","conditions":"Heart Failure","enrollment":25},{"nctId":"NCT04705727","phase":"PHASE3","title":"Budesonide/Formoterol Turbuhaler® Versus Terbutaline Nebulization as Reliever Therapy in Children With Moderate Asthma Exacerbation","status":"TERMINATED","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2021-08-23","conditions":"Asthma in Children","enrollment":102},{"nctId":"NCT03219736","phase":"NA","title":"NiPPV in the Treatment of Acute Asthma Exacerbations","status":"WITHDRAWN","sponsor":"Arkansas Children's Hospital Research Institute","startDate":"2017-06-01","conditions":"Bronchial Asthma, Status Asthmaticus","enrollment":""},{"nctId":"NCT05494307","phase":"PHASE2","title":"The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2022-09-01","conditions":"Immune Thrombocytopenia","enrollment":228},{"nctId":"NCT04468568","phase":"","title":"In Utero Repair of Myelomeningocele: Atosiban Versus Terbutaline","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2017-10-01","conditions":"Myelomeningocele, Terbutaline Adverse Reaction, Pregnancy; Malformation Central Nervous System","enrollment":25},{"nctId":"NCT05326269","phase":"NA","title":"Acute Tocolysis With Terbutaline for Suspected Fetal Distress","status":"COMPLETED","sponsor":"Hospital Kemaman","startDate":"2017-04-23","conditions":"Nonreassuring Fetal Status","enrollment":100},{"nctId":"NCT03877874","phase":"","title":"The Impact of Anti- Asthmatic Medications on Salivary pH and Dental Caries Pattern in a Group of Egyptian Children With Bronchial Asthma","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2021-07","conditions":"pH","enrollment":58},{"nctId":"NCT03106753","phase":"PHASE4","title":"Success of External Cephalic Version Study","status":"TERMINATED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2017-04-12","conditions":"External Cephalic Version","enrollment":34},{"nctId":"NCT04481282","phase":"PHASE2","title":"The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2020-07-08","conditions":"Immune Thrombocytopenia","enrollment":40},{"nctId":"NCT03565302","phase":"NA","title":"Beta2-adrenergic Agonism and Muscle Remodelling","status":"UNKNOWN","sponsor":"Morten Hostrup, PhD","startDate":"2018-06-25","conditions":"Hypertrophy, Physiologic Hypertrophy, Physical Activity","enrollment":72},{"nctId":"NCT02509299","phase":"NA","title":"Effect of Physiotherapy in Hospitalized COPD Patients","status":"COMPLETED","sponsor":"Universidad de Granada","startDate":"2019-09-01","conditions":"COPD","enrollment":49},{"nctId":"NCT02224157","phase":"PHASE3","title":"A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-11-28","conditions":"Asthma","enrollment":4215},{"nctId":"NCT02149199","phase":"PHASE3","title":"A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-07-07","conditions":"Asthma","enrollment":3850},{"nctId":"NCT04016220","phase":"PHASE1","title":"Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe Asthma","status":"UNKNOWN","sponsor":"University of Monastir","startDate":"2019-05-20","conditions":"Acute Asthma","enrollment":60},{"nctId":"NCT02515318","phase":"NA","title":"Physiotherapy in Acute Exacerbation of Chronic Obstructive Pulmonary Disease","status":"UNKNOWN","sponsor":"Universidad de Granada","startDate":"2015-09","conditions":"COPD","enrollment":60},{"nctId":"NCT01944033","phase":"PHASE3","title":"β2-agonist Versus Ipratropium Bromide Associated With β2-agonists in Chronic Obstructive Pulmonary Disease Exacerbation","status":"COMPLETED","sponsor":"University of Monastir","startDate":"2013-07","conditions":"Acute Exacerbation of Chronic Obstructive Airways Disease","enrollment":250},{"nctId":"NCT02557581","phase":"NA","title":"cAMP Signaling and Muscle Adaptations","status":"UNKNOWN","sponsor":"University of Copenhagen","startDate":"2015-07","conditions":"Muscle Hypertrophy in Healthy Young Men","enrollment":72},{"nctId":"NCT01582646","phase":"PHASE2","title":"Analgesic Effect of Beta 2-mimetics in the Treatment of Neuropathic Pain","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2012-01","conditions":"Postthoracotomy Pain, Postthoracoscopy Neuropathic Pain","enrollment":20},{"nctId":"NCT02115256","phase":"PHASE2, PHASE3","title":"Study to Evaluate is ECV Success is Improved and the Side Effects Reduced With the Use of IV NTGL Versus Terbutaline","status":"TERMINATED","sponsor":"Yaakov Beilin","startDate":"2014-07","conditions":"External Cephalic Version","enrollment":6},{"nctId":"NCT02178059","phase":"PHASE1","title":"Relative Bioavailability Study to Compare Inhalation of Terbutaline Sulphate 1,5mg Via Turbuhaler M3 With Turbuhaler M2","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-08","conditions":"Healthy Volunteers","enrollment":34},{"nctId":"NCT02712658","phase":"NA","title":"Role of K+ and Ca2+ in Development of Muscle Fatigue","status":"COMPLETED","sponsor":"University of Copenhagen","startDate":"2015-09","conditions":"Skeletal Muscle Fatigue in Humans","enrollment":10},{"nctId":"NCT02322788","phase":"PHASE3","title":"Comparing the Efficacy of Bricanyl M2 and Bricanyl M3 at 0.5 and 1.5 mg Dose Levels, to Allow for a Switch From Bricanyl Turbuhaler M2 to Bricanyl Turbuhaler M3","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2015-03","conditions":"Asthma","enrollment":95},{"nctId":"NCT02790047","phase":"NA","title":"Effect of Home-base Exercise With Conical-PEP Device on Physical Performance and Quality of Life in COPD","status":"UNKNOWN","sponsor":"Khon Kaen University","startDate":"2016-10","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":50},{"nctId":"NCT00607503","phase":"PHASE1","title":"A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes","status":"COMPLETED","sponsor":"Jaeb Center for Health Research","startDate":"2008-02","conditions":"Type 1 Diabetes","enrollment":9},{"nctId":"NCT02103374","phase":"PHASE4","title":"Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2012-01","conditions":"Severe Chronic Obstructive Pulmonary Disease","enrollment":45},{"nctId":"NCT00214318","phase":"NA","title":"Beta-2 Polymorphisms and Beta Receptor Selectivity","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2005-01","conditions":"Heart Failure","enrollment":25},{"nctId":"NCT02504801","phase":"PHASE4","title":"Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPD","status":"UNKNOWN","sponsor":"Xiuyi Zhi","startDate":"2015-07","conditions":"Post Operative Complication, Pulmonary, Lung Cancer, COPD","enrollment":73},{"nctId":"NCT01651962","phase":"PHASE4","title":"Intravenous Terbutaline to Facilitate Labor Epidural Catheter Placement","status":"UNKNOWN","sponsor":"Kai Schoenhage","startDate":"2012-08","conditions":"Labor Pain","enrollment":250},{"nctId":"NCT01081002","phase":"PHASE4","title":"Propofol Sedation During Upper Endoscopy With and Without Topical Pharyngeal Anesthesia","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2009-08","conditions":"Conscious Sedation","enrollment":294},{"nctId":"NCT00849095","phase":"PHASE3","title":"Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma","status":"COMPLETED","sponsor":"Università degli Studi di Ferrara","startDate":"2009-04","conditions":"Asthma","enrollment":860},{"nctId":"NCT00974051","phase":"NA","title":"Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2008-03","conditions":"Type 1 Diabetes","enrollment":16},{"nctId":"NCT00124995","phase":"PHASE4","title":"Trial of Terbutaline for the Treatment of Status Asthmaticus in Children","status":"COMPLETED","sponsor":"Connecticut Children's Medical Center","startDate":"2003-10","conditions":"Status Asthmaticus","enrollment":40},{"nctId":"NCT00839800","phase":"PHASE3","title":"Study to Investigate the Efficacy of Symbicort® SMART.","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2009-02","conditions":"Asthma","enrollment":2091},{"nctId":"NCT01096017","phase":"PHASE3","title":"To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2010-03","conditions":"Asthma","enrollment":24},{"nctId":"NCT00837967","phase":"PHASE3","title":"Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2009-01","conditions":"Asthma","enrollment":25},{"nctId":"NCT00989833","phase":"PHASE2","title":"Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2009-09","conditions":"Exercise Induced Asthma","enrollment":66},{"nctId":"NCT00518141","phase":"NA","title":"Use of Acetyl Salicylic Acid and Terbutalin in Assisted Reproductive Techniques (ART)","status":"COMPLETED","sponsor":"Sykehuset Telemark","startDate":"2006-03","conditions":"Reproductive Techniques, Assisted","enrollment":300},{"nctId":"NCT00567476","phase":"PHASE4","title":"Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma","status":"COMPLETED","sponsor":"Novartis","startDate":"2007-11","conditions":"Asthma","enrollment":116},{"nctId":"NCT00185887","phase":"NA","title":"Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation","status":"COMPLETED","sponsor":"Stanford University","startDate":"2003-10","conditions":"Fetal Distress","enrollment":110},{"nctId":"NCT00242775","phase":"PHASE3","title":"Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2005-05","conditions":"Asthma","enrollment":2100},{"nctId":"NCT00244608","phase":"PHASE3","title":"A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2005-05","conditions":"Asthma","enrollment":100},{"nctId":"NCT00259766","phase":"PHASE3","title":"SHARE - Symbicort and Health Economics in a Real Life Evaluation","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2004-04","conditions":"Asthma","enrollment":1970},{"nctId":"NCT00326053","phase":"PHASE3","title":"Prevention of Asthma Relapse After Discharge From Emergency","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2006-05","conditions":"Asthma","enrollment":600},{"nctId":"NCT01136421","phase":"PHASE3","title":"Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"University of Monastir","startDate":"2005-01","conditions":"COPD Exacerbation","enrollment":124},{"nctId":"NCT00668408","phase":"PHASE4","title":"LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure","status":"UNKNOWN","sponsor":"Azienda Ospedaliero-Universitaria Careggi","startDate":"2008-05","conditions":"Lung Diseases, Obstructive, Chronic Heart Failure, Chronic Hypoxemia","enrollment":1000},{"nctId":"NCT00914797","phase":"PHASE4","title":"Terbutaline Concentrations in Blood and Urine","status":"UNKNOWN","sponsor":"Bispebjerg Hospital","startDate":"2009-07","conditions":"Asthma","enrollment":30},{"nctId":"NCT00421122","phase":"PHASE3","title":"Efficacy and Safety Study of Symbicort Turbuhaler in Chinese Patients With COPD","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2006-09","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":315},{"nctId":"NCT00252863","phase":"PHASE3","title":"DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2004-12","conditions":"Asthma","enrollment":1600},{"nctId":"NCT00750568","phase":"","title":"Intravenous Terbutaline in Severe Status Asthmaticus","status":"UNKNOWN","sponsor":"Wayne State University","startDate":"2007-10","conditions":"Status Asthmaticus","enrollment":36}],"_emaApprovals":[],"_faersSignals":[{"count":17,"reaction":"DYSPNOEA"},{"count":10,"reaction":"CHEST DISCOMFORT"},{"count":8,"reaction":"ANAEMIA"},{"count":8,"reaction":"LACTIC ACIDOSIS"},{"count":7,"reaction":"ASTHMA"},{"count":7,"reaction":"THROMBOCYTOPENIA"},{"count":7,"reaction":"WHEEZING"},{"count":6,"reaction":"INFLUENZA LIKE ILLNESS"},{"count":6,"reaction":"LETHARGY"},{"count":6,"reaction":"NEUTROPENIA"}],"_approvalHistory":[],"publicationCount":142,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Terbutaline sulphate powder for inhalation, 0.5 mg (metered dose) terbutaline per inhalation","Terbutaline sulphate powder for inhalation, 0.4 mg (delivered dose) terbutaline per inhalation"],"phase":"phase_3","status":"active","brandName":"Terbutaline sulphate","genericName":"Terbutaline sulphate","companyName":"AstraZeneca","companyId":"astrazeneca","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Terbutaline sulphate is a beta-2 adrenergic receptor agonist that works by stimulating the beta-2 receptors in the lungs to cause bronchodilation. Used for Asthma, Chronic obstructive pulmonary disease (COPD).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}